Regenerative Medicine
Regenerative medicine seeks to replace tissue or organs that have been damaged by disease, trauma, or congenital issues, vs. the current clinical strategy that focuses primarily on treating the symptoms.
Click here to learn more about regenerative medicine from one of PMM's articles.
For any unfamiliar terms, please visit:
https://www.merriam-webster.com/medical
This table is searchable and sortable. Just click on a company logo to go to the company website or on the ad/banner/video to see an enlarged view. Simply click outside the image to return to normal view. The first row shows what a complete listing would look like. Click here to find out how you can get a company listing.
To return to the table listing all of our Directories, click here.
How to search PMM Directories
Simply enter your search terms into the search box located at the top of each Directory and then click on the blue search icon to the right. Search terms could include the name of a medical condition, type of innovation/technology, or company name, or any terms related to the condition or innovation type that you are interested in. For example, you could enter a term such as ´app´, ´gene´, ´cancer´, ´dementia´, ´epidermolysis bullosa´, or ´Pfizer´. You can also sort each of the columns alphabetically simply by clicking on the arrows that will appear to the right of the column´s name when you hover the mouse on that cell.
| Organization | Country | Innovation | Company Info | Logo | Ad/Banner/Video | Company News |
|---|---|---|---|---|---|---|
| Personalize My Medicine | UK | Platform for medical innovation | PMM keeps you informed about the latest advancements in medical innovation with a focus on personalized and precision medicine approaches to healthcare |  |  | Subscribe to PMM's free monthly newsletter here! |
| Aegle Therapeutics | US | isolating extracellular vesicles including exosomes (EVs) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (´DEB´), a rare genetic pediatric connective tissue disorder | ||||
| Aivita Biomedical | US | Use stem cell growth knowledge for cancer treatments | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Akron Bio | US | develop and manufacture stem cell products, cell culture products, and cGMP tools & technologies for the cell therapy industry | ||||
| Allarta Life Sciences Inc | Canada | platform technology to deliver curative cell and stem cell therapies | ||||
| AllCells | US | provider of high quality human primary blood and marrow-based cells | ||||
| Alliance for Regenerative Medicine | US | international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies | ||||
| Applied Stem Cell | US | building complete iPSC-Gene Editing platform for production of iPSC-derived products for gene and cell therapy research and development | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Aspen Neuroscience | US | leveraging our in-house stem cell biology and genomics platform to provide the world´s first autologous induced pluripotent stem cell (iPSC)-derived neuron replacement therapy for Parkinson´s Disease | ||||
| Atara Biotherapeutics | US | off-the-shelf, allogeneic T-cell immunotherapies | ||||
| Athersys | US | developing both stem cell therapy and pharmaceuticals | ||||
| Avery Therapeutics | US | Tissue engineered therapeutics to treat disease and injuries to human muscle | ||||
| Avita Medical | UK | regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| AVM Biotechnology | US | develops and delivers treatments that save lives and improve outcomes by unlocking the untapped potential of the body´s own immune system | ||||
| Axogen | US | technologies for peripheral nerve regeneration and repair | ||||
| BICO | US | Offers life science tools that enable human organ and tissue production. | ||||
| BioAesthetics | Ireland | Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. BioAesthetic´s initial product is a tissue-engineered nipple-areolar complex (NAC) | ||||
| BioCardia | US | developing novel therapeutics for cardiovascular diseases with large unmet medical needs | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Biorestorative therapeutics | US | Stem cell therapy for back pain caused by disc degeneration | ||||
| BioTalentum Ltd | Hungary | Developing & providing human stem cell-based solutions for disease modelling, in vitro toxicology, regenerative medicine | ||||
| BioTissue Ocular | US | regenerative medicine for ocular surface disease and injury, as well as ocular hygiene solutions for eye care professionals | ||||
| Bone Biologics | US | Developing target specific biological therapies for bone regeneration in human lumbar spinal fusion | ||||
| Bone Therapeutics | Belgium | developing innovative cell products for the repair and regeneration of bone and joint tissues | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Brainstorm Cell Therapeutics | US | developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders such as ALS (Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson´s disease (PD) | ||||
| Capricor Therapeutics | US | clinical-stage biotechnology company developing cell and exosome-based therapeutics for treatment and prevention of serious diseases. Lead candidate is allogeneic cell therapy in clinical development for treatment of Duchenne muscular dystrophy and complications associated with COVID-19 | ||||
| CardioCell | US | Stem cell technolog for cardiovascular indications | ||||
| Cell Care Therapeutics | US | Developing a new class of biologics derived from secreted proteins and exosomes of mesenchymal stromal cells (MSCs) to treat diabetic macular edema, leading cause of vision loss in working age adults | ||||
| Cell Line Genetics, Inc | US | independent provider of multi-species Quality Assurance services and products for the Regenerative Medicine market | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Cellaion | Belgium | Cell therapy for end stage liver diseases | ||||
| Cell-Easy | France | Produce cGMP cells for clinical advanced therapies. | ||||
| Celligenics | Singapore | biotechnology company specialised in the development of future-relevant solutions through stem cell technology in a new era of regenerative medicine. | ||||
| Celling Biosciences | US | developing point-of-care systems, innovative surgical techniques and technology platforms to create optimal environment for regenerative cell therapies to promote healing and regeneration of tissue | ||||
| Cellularity Inc. | US | allogeneic placenta-derived cellular therapies | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Chrysalis Biotherapeutics | US | developing regenerative drugs that mimic the bodyâs natural signals to activate endothelial progenitor cells and stem cells to stimulate tissue repair and restore normal tissue function | ||||
| Codiak Biosciences | US | Precision exosomes | ||||
| Coriell Institute for Medical Research | US | exploring the promise of induced pluripotent stem cells â stem cells created from skin or blood â and their role in disease research and drug discovery | ||||
| CRISPR therapeutics | US | gene editing | ||||
| Cynata Therapeutics | Australia | clinical-stage stem cell and regenerative medicine company focused on development of therapies based on proprietary therapeutic stem cell platform technology | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| DiscGenics | US | engineering highly specialized therapeutic progenitor cells (Discogenic Cells) that uniquely address the complex environment of the degenerated disc. | ||||
| ElevateBio | US | cell and gene therapies, gene editing, induced pluripotent stem cells, and protein, viral, and cellular engineering | ||||
| Evonik Corporation | Germany | polymer-based materials such as those used for resorbable implants | ||||
| Exopharm | Australia | Uses exosomes to deliver transformative treatments | ||||
| Fate Therapeutics | US | development of first-in-class cellular immunotherapies for patients with cancer | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Forticell Bioscience Inc | US | Composite cultured skin, a biologically active dressing that stimulates the repair, replacement and regeneration of human skin | ||||
| FUJIFILM Cellular Dynamics | US | manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells | ||||
| Harvard Stem Cell Institute | US | funding novel research and implementing collaborative academic and industrial models for advancing stem cell biology into the clinic | ||||
| Heartseed Inc | Tokyo | biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure | ||||
| Hemera Pharma | Italy | revolutionary cell therapy for the regeneration of damaged nervous tissues being applied to healing of spinal cord injuries in the sub-acute phase | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Histogen | Canada | Clinical-stage therapeutics company focussed on the development of restorative therapeutics that repair and maintain healthy biological function. | ||||
| Hubrecht Institute | Netherlands | performs research in the field of developmental biology and stem cell research | ||||
| Humacyte | US | developing universally implantable bioengineered human tissues & organs | ||||
| Indee Labs | US | Creating technology that accelerates the development and manufacture of engineered cell therapies | ||||
| Institute for Stem Cell Science and Regenerative Medicine (DBT-inStem) | Bangalore, Karnataka | Examines clinical manifestations of diseases that can be potentially treated by stem cells, develops tools to better understand the biology driving stem cells and eventually treat disease states | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Integra Life Sciences | US | Soft tissue reconstruction, comprehensive solutions in tissue regeneration for acute and chronic complex wounds and burns. | ||||
| International Society for Stem Cell Research | US | largest society in the world dedicated to the advancement of responsible stem cell research | ||||
| InVitro Cell Research, LLC | US | discovering and developing interventions to slow and reverse biological aging and prevent major age-related diseases | ||||
| JangoBio | US | developing regenerative therapies to reverse hormone imbalances associated with aging to mitigate risk of developing wide range of age-related diseases | ||||
| Jointechlabs | US | non-surgical regenerative medicine therapies at the point-of-care | ||||
| Juventus Therapeutics | US | Biotech company developing regenerative therapies for life-threatening diseases. | ||||
| Kerecis | Iceland | Marine-derived tissue engineering | ||||
| Magenta Therapeutics | US | clinical-stage biotechnology company developing stem cell transplants for patients with blood cancers, genetic diseases, and autoimmune diseases | ||||
| Medtronic | UK | Medical solutions in a wide range of conditions including cardiovascular, neurolohical, and respiratory diseases | ||||
| Mesoblast Ltd | USA | developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical needs | ||||
| MiMedX | US | human placental tissue allografts | ||||
| Omega Therapeutics | US | broad pipeline of development candidates spanning a range of disease areas, including oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases | ||||
| Orchard Therapeutics | UK | developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy | ||||
| Organicell | US | extracellular vesicle therapeutics | ||||
| Organogenesis | US | Antimicrobial wound matrices | ||||
| Orgenesis | US | Cell & Gene Therapy Biotech Platform. | ||||
| Oxartis | UK | Next-generation regenerative tissue engineering products for skin, soft tissue and bone reconstruction. | ||||
| Poseida Therapeutics, Inc. | US | cell and gene therapies | ||||
| Prellis Biologics | US | 3D printed lymph nodes to recreate human immunology in vitro | ||||
| Regeneus | Australia | Cell-based therapies with a focus on osteoarthritis, neuropathic pain and dermatology. | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Regenexx | US | Stem cell therapy for Arthritis | ||||
| RoosterBio Inc. | US | adult human mesenchymal stem/stromal cells (hMSCs) | ||||
| Rubius Therapeutics | US | genetically engineer and culture Red Cell Therapeutics⢠that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas | ||||
| RxGenesys Biotechnology | US | development of wound healing and skin care solutions and compounds based on the novel microRNA and iPS (induced pluripotent stem cell) technologies | ||||
| Sana Biotechnology, Inc. | US | cell & gene therapy, developing treatments for patients with poor outcomes or currently untreatable diseases | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Sanford Burnham Prebys | US | independent biomedical research institute dedicated to understanding basic human biology and disease and advancing scientific discoveries to profoundly impact human health | ||||
| Sanofi Genzyme | UK | Use a variety of modalities to tackle skin cancer | ||||
| Sarah Cannon | US | individualized patient navigation provided by oncology-trained nurses, ~1,200 stem cell transplants performed annually, clinical trials, and molecular profiling capabilities | ||||
| Seraxis | US | developing cell replacement therapy for insulin-dependent diabetes | ||||
| Smith & Nephew | UK | Collagen implants to support the body's natural healing response and facilitate new tendon-like tissue growth | ||||
| Spiderwort | Canada | Cellulose-based biomaterials for repair and regeneration of human tissues | ||||
| Stem Cell Institute | US | Adult stem cell therapy reesarch centre, using allogenic human umbilical cord stem cells and autologous bone marrow stem cells to treat multiple diseases including osteoarthritis and autoimmune diseases | ||||
| Stem Cell Theranostics | US | Develop genetically-targted therapies for heart failure. | ||||
| Stem Center S.L.U | Baleric Islands | Working and developing new lines of research using cellular surgery for new indications in plastic and reconstructive surgery as well as in other fields such as orthopaedic surgery, lymphatic system disorders, etc. | ||||
| StemRemedium | US | develop innovative treatments for chronic disease and injury through breakthrough cellular technologies and medical devices | ||||
| Tempo Therapeutics | US | building functional tissue and organs within patients, in real time, to treat disease, and developing next-generation vaccine technologies that are shelf stable, stockpile-able, and protect against multiple diseases with a single injection | ||||
| TeVido Biodevices | US | skin cell transplants to restore lost skin color | ||||
| Texas Heart Institute | US | research programs in cardiology, cardiovascular surgery, stem cell and gene therapy, and regenerative medicine | ||||
| The Cell Fate Engineering and Therapeutics Laboratory | Singapore | Developing therapeutics through cell fate engineering. Working with human and mouse embryonic stem cells via technologies such as CRISPR screening | ||||
| The New York Stem Cell Foundation | US | innovative stem cell research | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| UniCyte AG | Switzerland | dvancing stem cell technologies into a novel class of human therapeutics | ||||
| ViaCyte | US | developing novel cell replacement therapies as potential long-term diabetes treatments | ||||
| Videregen | UK | Uses tissue processing technology to develop high quality standardised tissue restoration products. | ||||
| Vita Therapeutics | US | utilizes induced pluripotent stem cell (iPSC) technology to develop regenerative therapies designed to support muscle regeneration and treat patients with muscle disorders | ||||
| Vivex Biologics | US | allograft solutions designed to support the bodyâs healing and regenerative potential | The first row shows what your upgraded listing would look like. Click here to find out how you can upgrade your company's listing. | |||
| Vor Biopharma | US | clinical-stage cell and genome engineering company engineering hematopoietic stem cells to enable targeted therapies post-transplant | ||||
| Walking Fish Therapeutics | US | Cell based therapeutics for regenerative therapies |